The prostate-specific membrane antigen (PSMA) is a transmembrane glycoprotein that is significantly overexpressed in most prostate adenocarcinomas, compared with other PSMA-expressing tissues [4]. Here, FOLH1 is linked to prostate adenocarcinoma.